Chris Ryan

See the following -

Viratech Announces Agreement For License Of Technology Platform For Cancer Patients

Press Release | Cancer.im, Viratech Corp. | May 30, 2013

Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for a license issued from Chris Ryan and Kevin Buckman for a patent-pending, provisional application titled "Method of Lowering a Cancer Patient's Morbidity Rate by Increasing Quality of Life of Patient by Leveraging Cause-Based Electronic Social Support Networks." Read More »